The United States of America has started the first human trial of a vaccine to protect people from the pandemic coronavirus. In the Kaiser Permanente research facility located in Seattle, Washington, four patients were given the vaccine.

It has been said that this vaccine will not cause Covid-19 and that it comprises a genetic code which has been replicated from the genetic code of the virus that has been affecting people. It has been estimated that it will take several months to determine if this vaccine will be effective against Coronavirus.

A 43-year-old mother-of-two from Seattle was the first to get the vaccine. As per reports, this human trial which is funded by the National Institutes of Health avoids the usual check done to ensure that the vaccine can stimulate immunity.

Moderna Therapeutics, the biotech organization which is working on the vaccine has said that it has been designed in a tested process.